Brief: Xilio Therapeutics Reports Pipeline And Business Highlights And First Quarter 2022 Financial Results
12/05/2022 12:32
May 12 (Reuters) - Xilio Therapeutics Inc XLO.O :
* XILIO THERAPEUTICS REPORTS PIPELINE AND BUSINESS
HIGHLIGHTS AND
FIRST QUARTER 2022 FINANCIAL RESULTS
* CASH RUNWAY ANTICIPATED INTO FIRST HALF OF 2024
* ON TRACK WITH PLANS TO SUBMIT IND FOR XTX301, A
TUMOR-SELECTIVE
IL-12, IN SECOND HALF OF 2022
* QTRLY LOSS PER SHARE $0.78
* Q1 EARNINGS PER SHARE VIEW $-0.93 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXJ70p8
Further company coverage: XLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla